SBI PHARMACEUTICALS CO., LTD.
🇯🇵Japan
- Country
- 🇯🇵Japan
- Ownership
- Subsidiary
- Established
- 2008-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://www.sbipharma.co.jp
Clinical Trials
7
Active:1
Completed:4
Trial Phases
3 Phases
Phase 2:2
Phase 3:2
Not Applicable:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (5 trials with phase data)• Click on a phase to view related trials
Phase 2
2 (40.0%)Phase 3
2 (40.0%)Not Applicable
1 (20.0%)Pilot Study to Evaluate the Safety and Efficacy of 5-ALA-SFC in Type II Diabetes
Not Applicable
Completed
- Conditions
- Diabetes Mellitus, Type 2
- Interventions
- Drug: 5-ALA-SFCDrug: Placebo
- First Posted Date
- 2015-06-25
- Last Posted Date
- 2018-05-22
- Lead Sponsor
- SBI Pharmaceuticals Co, Ltd.
- Target Recruit Count
- 53
- Registration Number
- NCT02481141
News
No news found